Igor Luna Peixoto

Igor Luna Peixoto

Auto-generated profile, based on publicly available information

Igor Luna Peixoto

Hospital Universitário Evangélico Mackenzie de Curitiba

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
FTFernando Torterolli
Fernando Torterolli
RWRafael Katsunori Watanabe
Rafael Katsunori Watanabe
FTFERNANDO TABUSHI
FERNANDO TABUSHI
IPIgor Luna Peixoto
Igor Luna Peixoto
PNPaulo Afonso Nunes Nassif
Paulo Afonso Nunes Nassif
OMOsvaldo Malafaia
Osvaldo Malafaia
Background: Liver transplantation is the treatment of choice for patients with terminal liver disease. The Balance of Risk Score (BAR), Survival Outcomes Following Liver Transplantation (SOFT) and Donor Risk Index (DRI) scores are predictive systems for post-transplant survival. Aim: To evaluate the most accurate score and the best cutoff point for each predictor in the brazilian population. Method: Retrospective cross-sectional study of 177 patients. Data on the recipient, donor and transplant were analyzed and the prognostic scores BAR, SOFT and DRI were calculated for each transplant. To determine the BAR and SOFT cutoff points associated with death in three months, ROC curves were adjusted. Results: The best cutoff point for BAR was 9 points with an area under the ROC curve=0.69 and for SOFT it was 12 points with an area under the ROC curve=0.73. The DRI score did not discriminate survival (p = 0.139). Conclusion: The SOFT score proved to be better than BAR for survival analysis post-hepatic transplantation and the DRI was not effective.

24 June 2022 in REVISTA MÉDICA DO PARANÁ
Verified
Journal Article
Open access
PDF file
ACAndrea Lima Conde
Andrea Lima Conde
ALAndré Montes Luz
André Montes Luz
BPBruno Perotta
Bruno Perotta
CMCarlos Hespanha Marinho-Junior
Carlos Hespanha Marinho-Junior
MRMauricio Marcondes Ribas
Mauricio Marcondes Ribas
IPIgor Luna Peixoto
Igor Luna Peixoto
- The use of midazolam and fentanyl for conscious sedation in digestive endoscopy is an option; however, propofol has been increasingly used. The aim of this study was to identify risk factors to predict the need for propofol use in patients undergoing digestive endoscopy. It is a retrospective study in which 620 patients undergoing upper digestive endoscopy and colonoscopy or both procedures were evaluated. Epidemiological variables and associated diseases were analyzed. In conclusion, epidemiological factors did not present themselves as risk factors related to the increase in the dose and use of propofol, but there was a need for those with psychiatric disease, when they did not receive sedation with midazolam, fentanyl, and when they underwent a combined procedure. RESUMO - O uso de midazolam e fentanil é para realização de sedação consciente em endoscopia digestiva é opção; porém, o propofol vem sendo cada vez mais utilizado. O objetivo deste estudo foi identificar dos fatores de risco para prever a necessidade de uso de propofol em pacientes submetidos à endoscopia digestiva. È estudo retrospectivo em que foram avaliados 620 pacientes submetidos à endoscopia digestiva alta e colonoscopia ou ambos os procedimentos. Foram analisados variáveis epidemiológicas e doenças associadas. Em conclusão, epidemiológicas não se apresentaram como fatores de risco relacionados ao aumento da dose e uso do propofol, mas houve necessidade de aumento naqueles com doença psiquiátrica, quando não receberam sedação com midazolam, fentanil, e quando foram submetidos a procedimento combinado.